Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia Burden
Weiping Zhang(University of Pittsburgh), Jianmin Wang(Changhai Hospital), Hui Cheng(Second Military Medical University), Baohai Liu(Jinzhou Medical University), Hong Zhou(Army Medical University), Jie Chen(Second Military Medical University), Hongmei Li(Second Military Medical University), Li Chen(First Affiliated Hospital Zhejiang University), Dan Yang(University of Hong Kong), Xianmin Song(Shanghai First People's Hospital), Xiong Ni(Second Military Medical University), Jianmin Yang(Canadian Food Inspection Agency)
Cited by 39
Related Papers
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
|Nature Genetics|2011|2k
The effect of genotype and in utero environment on interindividual variation in neonate DNA methylomes
|Genome Research|2014|360
An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
|Cancer Cell|2012|276
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256